- Home
- LBRDA vs NBIX Comparison
LBRDA vs NBIX Comparison
Compare LBRDA & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDA
- NBIX
- Stock Information
- Founded
- LBRDA 2014
- NBIX 1992
- Country
- LBRDA United States
- NBIX United States
- Employees
- LBRDA N/A
- NBIX N/A
- Industry
- LBRDA Cable & Other Pay Television Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LBRDA Telecommunications
- NBIX Health Care
- Exchange
- LBRDA Nasdaq
- NBIX Nasdaq
- Market Cap
- LBRDA 11.2B
- NBIX 11.0B
- IPO Year
- LBRDA N/A
- NBIX 1996
- Fundamental
- Price
- LBRDA $91.92
- NBIX $115.71
- Analyst Decision
- LBRDA Buy
- NBIX Strong Buy
- Analyst Count
- LBRDA 3
- NBIX 20
- Target Price
- LBRDA $94.00
- NBIX $163.20
- AVG Volume (30 Days)
- LBRDA 137.8K
- NBIX 1.9M
- Earning Date
- LBRDA 05-07-2025
- NBIX 05-05-2025
- Dividend Yield
- LBRDA N/A
- NBIX N/A
- EPS Growth
- LBRDA 6.21
- NBIX N/A
- EPS
- LBRDA 6.26
- NBIX 2.96
- Revenue
- LBRDA $1,037,000,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- LBRDA $5.22
- NBIX $15.36
- Revenue Next Year
- LBRDA $2.34
- NBIX $16.34
- P/E Ratio
- LBRDA $14.83
- NBIX $39.13
- Revenue Growth
- LBRDA 5.82
- NBIX 21.73
- 52 Week Low
- LBRDA $49.68
- NBIX $84.23
- 52 Week High
- LBRDA $100.44
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- LBRDA 65.84
- NBIX 60.88
- Support Level
- LBRDA $86.80
- NBIX $105.45
- Resistance Level
- LBRDA $93.59
- NBIX $130.46
- Average True Range (ATR)
- LBRDA 2.58
- NBIX 4.31
- MACD
- LBRDA 1.18
- NBIX 1.96
- Stochastic Oscillator
- LBRDA 91.75
- NBIX 50.22
About LBRDA Liberty Broadband Corporation
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential and small to medium businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.